Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with p-glycoprotein expression in patients with untreted small cell lung cancer
- 23 Downloads
The purpose of this study was to predict chemotherapy response by technetium-99m methoxy-isobutylisonitrile (Tc-99m MIBI) lung single-photon-emission computed tomography (SPECT) and compare P-glycoprotein (Pgp) expression in patients with untreated small cell lung cancer (SCLC). Before chemotherapy, 40 patients with untreated SCLC underwent Tc-99m MIBI lung SPECT. Immunohistochemical analyses were performed using multiple nonconsecutive sections of the biopsy specimens to detect Pgp expression. Chemotherapy response was evaluated in the third month after completion of treatment by clinical and radiological methods. Based on quantitative analyses, the tumor uptake ratios (TUR) of the 20 patients with good response (1.89±0.28) were significantly higher than that of the 20 patients with poor response (1.21±0.28) (p value<0.05). Based on visual interpretation, all of the 20 patients (100%) with good response had positive Tc-99m TF lung SPECT findings and negative Pgp expression. Five of the other 20 patients (25%) with poor response had positive Tc-99m MIBI lung SPECT findings, and 12 of the other 20 patients (60%) with poor response had negative Pgp expression (p value<0.05). Negative Tc-99m MIBI lung SPECT findings could predict poor response. Therefore, we concluded that Tc-99m MIBI lung SPECT can accurately predict the chemotherapy response, and Tc-99m MIBI lung SPECT findings can be partially compatible with Pgp expression in patients with untreated SCLC.
Key WordsTechnetium-99m methoxyisobutylisonitrile single-photon-emission computed tomography small cell lung cancer chemotherapy P-glycoprotein
Unable to display preview. Download preview PDF.
- 1.Lassen U, Hansen HH: Small cell carcinoma of the lung. In Cancer treatment, edited by CM Haskell, JS Berek, Philadelphia, W B Saunders, 1995, pp. 414–420.Google Scholar
- 2.Smit EF, Postmus PE: Chemotherapy of small cell lung cancer. In Carney DN (ed). Lung cancer. The Bath Press, Avon, London, 1995, pp. 156–172.Google Scholar
- 3.Berlin J, Schiller JH: Chemotherapy of small-cell carcinoma of the lung. In Johnson BE, Johnson DH (eds). Lung cancer. Wiley-Liss, New York, 1995, pp. 247–261.Google Scholar
- 5.Twentyman PR. Mechanism of drug resistance in lung cancer cells. In Carney DN (ed). Lung cancer. The Bath Press, Avon, London. 1995.Google Scholar
- 6.Beck W, Dalton WS: Mechanisms of drug resistance. In DeVita VT Jr, et al. (eds.) Cancer: principles and practice of oncology. JB Lippincott, Philadelphia, 1997.Google Scholar
- 21.Neal AJ, Hoskin PJ: Lung cancer and mesothelioma. In Neal AJ, Hoskin PJ (eds). Clinical oncology: basic principles and practice. Arnold, London, 1997, pp. 42–55.Google Scholar